Myla Lai-Goldman
Directeur/Membre du Conseil chez WEST PHARMACEUTICAL SERVICES, INC.
Fortune : 7 M $ au 30/04/2024
Profil
Dr. Myla P.
Lai-Goldman is an Independent Director at Akoya Biosciences, Inc., an Independent Director at West Pharmaceutical Services, Inc., a Venture Partner at Hatteras Venture Partners, an Executive Chairman at GeneCentric Therapeutics, Inc. and a Managing Partner at Personalized Science LLC.
She is on the Board of Directors at Mercy Bioanalytics, Inc., Akoya Biosciences, Inc., West Pharmaceutical Services, Inc., Council for Entrepreneurial Development, NovoPath LLC and Qvella Corp.
Dr. Lai-Goldman was previously employed as an Independent Director by Sequenom, Inc., a Chief Executive & Scientific Officer by CancerGuide Diagnostics, Inc., a Medical Director by Center for Molecular Biology & Pathology, an Executive VP, Chief Medical & Scientific Officer by Laboratory Corp.
of America Holdings, a Principal by National Genetics Institute, Inc., an Executive VP, Chief Medical & Scientific Officer by Roche Biomedical Laboratories, Inc., and a Principal by Viro-Med Laboratories, Inc. She received her undergraduate degree from the University of Pennsylvania and a doctorate degree from The Trustees of Columbia University in The City of New York.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 23/04/2024 | 18 353 ( 0,03% ) | 7 M $ | 30/04/2024 | |
AKOYA BIOSCIENCES INC
0,04% | 31/03/2024 | 20 000 ( 0,04% ) | 76 400 $ | 30/04/2024 |
Postes actifs de Myla Lai-Goldman
| Sociétés | Poste | Début |
|---|---|---|
| WEST PHARMACEUTICAL SERVICES, INC. | Directeur/Membre du Conseil | 17/02/2014 |
| AKOYA BIOSCIENCES, INC. | Directeur/Membre du Conseil | 16/09/2021 |
NovoPath LLC
 NovoPath LLC Packaged SoftwareTechnology Services NovoPath LLC is a laboratory information systems company based in Bridgewater, NJ. The company has been recognized for innovation and has developed a SaaS-based platform called NovoPath 360 that enables anatomic and clinical pathology labs worldwide to automate, track, simplify, and complete complex cases from heme to derm faster than ever. NovoPath LIS is the most intuitive and robust laboratory information system that deploys automation, generates insightful patient reports, facilitates workflow adjustments, and helps drive innovation. The CEO of the company is Promise Okeke. | Directeur/Membre du Conseil | - |
Qvella Corp.
 Qvella Corp. Medical SpecialtiesHealth Technology Qvella Corp provides molecular diagnostics. It develops a differentiated technology for pathogen detection by direct sampling of boldily fluids without the need for culturing or time consuming sample processing. The company was founded by Tino Alavie in 2009 and is headquartered in Richmond Hill, Canada. | Directeur/Membre du Conseil | - |
Mercy Bioanalytics, Inc.
 Mercy Bioanalytics, Inc. Pharmaceuticals: MajorHealth Technology The American company was founded in 2018 by Joseph Sedlak and Paul W. Blavin, and Dawn R. Mattoon has been the CEO of the company since 2022. Mercy Bioanalytics utilizes the patented Mercy Halo liquid biopsy platform to detect stage I cancer, which is most treatable, by analyzing single extracellular vesicles (EVs) that carry unique cancer signatures from their parent cells. The company's initial focus is on the early detection of ovarian and lung cancers, which are difficult to detect and often go undetected until it is too late to cure. The Mercy Halo test makes early-stage cancer detection 100,000 times easier by analyzing EVs found in blood that are specific to their parent cells. | Directeur/Membre du Conseil | 24/04/2023 |
Council for Entrepreneurial Development
 Council for Entrepreneurial Development Miscellaneous Commercial ServicesCommercial Services Council for Entrepreneurial Development provides an interactive forum for entrepreneurs, investors, service professionals, academicians, researchers and public policy makers. Its services and programs include connections to capital, venture mentoring, and signature conferences empower member companies to go further. The company was founded in 1984 and is headquartered in Durham, NC. | Directeur/Membre du Conseil | - |
GeneCentric Therapeutics, Inc.
 GeneCentric Therapeutics, Inc. Medical SpecialtiesHealth Technology GeneCentric Therapeutics, Inc. develops and commercializes molecular diagnostic assays. Its product enables oncologists and patients to make more informed, individualized treatment decisions. The firm's product CSP identifies cancer subtypes that enable drug developers to meet the growing demand for precision medicines, and provide clinicians the information they need to make individualized treatment decisions. The company was founded by David Neil Hayes, Charles M. Perou, and Myla P. Lai-Goldman in 2011 and is headquartered in Durham, NC. | Fondateur | 01/01/2011 |
Personalized Science LLC
 Personalized Science LLC Miscellaneous Commercial ServicesCommercial Services Personalized Science LLC operates as a consulting company. It offers consulting services, The company was founded by Myla Lai-Goldman in 2009 and is headquartered in Chapel Hill, NC. | Fondateur | 01/01/2009 |
Hatteras Venture Partners
 Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | Private Equity Investor | 01/08/2011 |
Anciens postes connus de Myla Lai-Goldman
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Myla Lai-Goldman
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| University of Pennsylvania | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| WEST PHARMACEUTICAL SERVICES, INC. | Health Technology |
| AKOYA BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 14 |
|---|---|
Laboratory Corp. of America Holdings
 Laboratory Corp. of America Holdings Services to the Health IndustryHealth Services Laboratory Corp. of America Holdings operates as a life sciences company, which engages in the provision of vital information to help health professionals make clear and confident decisions. It operates through the Drug Development and Diagnostics segments. The Drug Development segment consists of lead optimization, preclinical safety assessment, analytical services, clinical trials, central laboratories, biomarkers, and companion diagnostics, market access, and technology solutions. The Diagnostics segment includes primary care, women's health, specialty medicine, oncology, ACOs, and hospitals and health systems. The company was founded in 1971 and is headquartered in Burlington, NC. | Health Services |
Sequenom, Inc.
 Sequenom, Inc. Medical SpecialtiesHealth Technology Sequenom, Inc. engages in the provision of early patient management information. It develops and commercializes molecular diagnostic testing services that serve women's health and oncology markets. The company was founded by Hubert Koester and Charles R. Cantor in October 09, 1996 and is headquartered in Burlington, NC. | Health Technology |
CancerGuide Diagnostics, Inc.
 CancerGuide Diagnostics, Inc. Medical/Nursing ServicesHealth Services CancerGuide Diagnostics was founded and launched by experienced individuals, passionate about fulfilling the unmet needs in current cancer care and drug development. CancerGuide Diagnostics'™ vision is to dramatically improve the management of cancer by providing physicians with advanced molecular diagnostics that enable individualized treatment decisions. CancerGuide is a singularly focused diagnostic product and services company that is actively licensing high-value, novel technology that may improve the quality of life for those living with cancer. Through its collaboration with Laboratory Corporation of America® Holdings (LabCorp®), CancerGuide provides an innovative development-to-commercial market platform for emerging molecular oncology diagnostic technologies. In addition to its internal diagnostic development programs, CancerGuide provides companion diagnostic development services, including tumor profiling and signature development services, to pharmaceutical and biotechnology companies to help maximize the efficiency and effectiveness of cancer therapy pipelines. | Health Services |
GeneCentric Therapeutics, Inc.
GeneCentric Therapeutics, Inc. Medical SpecialtiesHealth Technology GeneCentric Therapeutics, Inc. develops and commercializes molecular diagnostic assays. Its product enables oncologists and patients to make more informed, individualized treatment decisions. The firm's product CSP identifies cancer subtypes that enable drug developers to meet the growing demand for precision medicines, and provide clinicians the information they need to make individualized treatment decisions. The company was founded by David Neil Hayes, Charles M. Perou, and Myla P. Lai-Goldman in 2011 and is headquartered in Durham, NC. | Health Technology |
| Roche Biomedical Laboratories, Inc. | Health Technology |
National Genetics Institute, Inc.
 National Genetics Institute, Inc. Chemicals: SpecialtyProcess Industries Part of Laboratory Corp. of America Holdings, National Genetics Institute, Inc. provides hepatitis C testing and other laboratory services. The company is based in Los Angeles, CA. The company was founded by Andrew J. Conrad, Michael A. Aicher. National Genetics Institute was acquired by Laboratory Corp. of America Holdings on August 01, 2000. | Process Industries |
Hatteras Venture Partners
Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | Finance |
Council for Entrepreneurial Development
Council for Entrepreneurial Development Miscellaneous Commercial ServicesCommercial Services Council for Entrepreneurial Development provides an interactive forum for entrepreneurs, investors, service professionals, academicians, researchers and public policy makers. Its services and programs include connections to capital, venture mentoring, and signature conferences empower member companies to go further. The company was founded in 1984 and is headquartered in Durham, NC. | Commercial Services |
Viro-Med Laboratories, Inc.
 Viro-Med Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Viro-Med Laboratories, Inc. engages in the provision of diagnostic testing in virology, molecular biology, serology, microbiology, mycology, and mycobacteriology. The company was established in 1982 and is headquartered in Minneapolis, MN. | Commercial Services |
| Center for Molecular Biology & Pathology | |
Personalized Science LLC
Personalized Science LLC Miscellaneous Commercial ServicesCommercial Services Personalized Science LLC operates as a consulting company. It offers consulting services, The company was founded by Myla Lai-Goldman in 2009 and is headquartered in Chapel Hill, NC. | Commercial Services |
Qvella Corp.
Qvella Corp. Medical SpecialtiesHealth Technology Qvella Corp provides molecular diagnostics. It develops a differentiated technology for pathogen detection by direct sampling of boldily fluids without the need for culturing or time consuming sample processing. The company was founded by Tino Alavie in 2009 and is headquartered in Richmond Hill, Canada. | Health Technology |
Mercy Bioanalytics, Inc.
Mercy Bioanalytics, Inc. Pharmaceuticals: MajorHealth Technology The American company was founded in 2018 by Joseph Sedlak and Paul W. Blavin, and Dawn R. Mattoon has been the CEO of the company since 2022. Mercy Bioanalytics utilizes the patented Mercy Halo liquid biopsy platform to detect stage I cancer, which is most treatable, by analyzing single extracellular vesicles (EVs) that carry unique cancer signatures from their parent cells. The company's initial focus is on the early detection of ovarian and lung cancers, which are difficult to detect and often go undetected until it is too late to cure. The Mercy Halo test makes early-stage cancer detection 100,000 times easier by analyzing EVs found in blood that are specific to their parent cells. | Health Technology |
NovoPath LLC
NovoPath LLC Packaged SoftwareTechnology Services NovoPath LLC is a laboratory information systems company based in Bridgewater, NJ. The company has been recognized for innovation and has developed a SaaS-based platform called NovoPath 360 that enables anatomic and clinical pathology labs worldwide to automate, track, simplify, and complete complex cases from heme to derm faster than ever. NovoPath LIS is the most intuitive and robust laboratory information system that deploys automation, generates insightful patient reports, facilitates workflow adjustments, and helps drive innovation. The CEO of the company is Promise Okeke. | Technology Services |